Intralesional Bevacizumab for Treating AIDS-associated Kaposi's Sarcoma of the Larynx, Pharynx and Oral Cavity
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Bevacizumab (Primary) ; Antiretrovirals
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
Most Recent Events
- 15 Feb 2011 New trial record